Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 154

1.

Identification of the XPG region that causes the onset of Cockayne syndrome by using Xpg mutant mice generated by the cDNA-mediated knock-in method.

Shiomi N, Kito S, Oyama M, Matsunaga T, Harada YN, Ikawa M, Okabe M, Shiomi T.

Mol Cell Biol. 2004 May;24(9):3712-9.

2.

Severe growth retardation and short life span of double-mutant mice lacking Xpa and exon 15 of Xpg.

Shiomi N, Mori M, Kito S, Harada YN, Tanaka K, Shiomi T.

DNA Repair (Amst). 2005 Mar 2;4(3):351-7.

PMID:
15661658
3.

Complementation of transformed fibroblasts from patients with combined xeroderma pigmentosum-Cockayne syndrome.

Ellison AR, Nouspikel T, Jaspers NG, Clarkson SG, Gruenert DC.

Exp Cell Res. 1998 Aug 25;243(1):22-8.

PMID:
9716445
4.

Cerebro-oculo-facio-skeletal syndrome with a nucleotide excision-repair defect and a mutated XPD gene, with prenatal diagnosis in a triplet pregnancy.

Graham JM Jr, Anyane-Yeboa K, Raams A, Appeldoorn E, Kleijer WJ, Garritsen VH, Busch D, Edersheim TG, Jaspers NG.

Am J Hum Genet. 2001 Aug;69(2):291-300. Epub 2001 Jul 3.

6.
7.

Definition of a short region of XPG necessary for TFIIH interaction and stable recruitment to sites of UV damage.

Thorel F, Constantinou A, Dunand-Sauthier I, Nouspikel T, Lalle P, Raams A, Jaspers NG, Vermeulen W, Shivji MK, Wood RD, Clarkson SG.

Mol Cell Biol. 2004 Dec;24(24):10670-80.

8.

Novel XPG (ERCC5) mutations affect DNA repair and cell survival after ultraviolet but not oxidative stress.

Soltys DT, Rocha CR, Lerner LK, de Souza TA, Munford V, Cabral F, Nardo T, Stefanini M, Sarasin A, Cabral-Neto JB, Menck CF.

Hum Mutat. 2013 Mar;34(3):481-9. doi: 10.1002/humu.22259. Epub 2013 Jan 17.

PMID:
23255472
9.

Characterization of three XPG-defective patients identifies three missense mutations that impair repair and transcription.

Schäfer A, Schubert S, Gratchev A, Seebode C, Apel A, Laspe P, Hofmann L, Ohlenbusch A, Mori T, Kobayashi N, Schürer A, Schön MP, Emmert S.

J Invest Dermatol. 2013 Jul;133(7):1841-9. doi: 10.1038/jid.2013.54. Epub 2013 Jan 31.

10.
11.

XPG stabilizes TFIIH, allowing transactivation of nuclear receptors: implications for Cockayne syndrome in XP-G/CS patients.

Ito S, Kuraoka I, Chymkowitch P, Compe E, Takedachi A, Ishigami C, Coin F, Egly JM, Tanaka K.

Mol Cell. 2007 Apr 27;26(2):231-43.

12.

A genetic mouse model carrying the nonfunctional xeroderma pigmentosum group G gene.

Sun XZ, Harada YN, Zhang R, Cui C, Takahashi S, Fukui Y.

Congenit Anom (Kyoto). 2003 Jun;43(2):133-9. Review.

PMID:
12893972
13.

Postnatal growth failure, short life span, and early onset of cellular senescence and subsequent immortalization in mice lacking the xeroderma pigmentosum group G gene.

Harada YN, Shiomi N, Koike M, Ikawa M, Okabe M, Hirota S, Kitamura Y, Kitagawa M, Matsunaga T, Nikaido O, Shiomi T.

Mol Cell Biol. 1999 Mar;19(3):2366-72.

14.

Roles of XPG and XPF/ERCC1 endonucleases in UV-induced immunostaining of PCNA in fibroblasts.

Miura M, Nakamura S, Sasaki T, Takasaki Y, Shiomi T, Yamaizumi M.

Exp Cell Res. 1996 Jul 10;226(1):126-32.

PMID:
8660947
15.

UVB radiation-induced cancer predisposition in Cockayne syndrome group A (Csa) mutant mice.

van der Horst GT, Meira L, Gorgels TG, de Wit J, Velasco-Miguel S, Richardson JA, Kamp Y, Vreeswijk MP, Smit B, Bootsma D, Hoeijmakers JH, Friedberg EC.

DNA Repair (Amst). 2002 Feb 28;1(2):143-57.

PMID:
12509261
16.

Conserved residues of human XPG protein important for nuclease activity and function in nucleotide excision repair.

Constantinou A, Gunz D, Evans E, Lalle P, Bates PA, Wood RD, Clarkson SG.

J Biol Chem. 1999 Feb 26;274(9):5637-48.

17.

Enhancement of XPG mRNA transcription by human interferon-beta in Cockayne syndrome cells with complementation group B.

Suzuki Y, Sugita K, Suzuki N, Kita K, Higuchi Y, Yamaura A, Kohno Y.

Int J Mol Med. 1999 Jan;3(1):87-9.

PMID:
9864391
18.

Enhancement of XPG mRNA expression by human interferon-beta in Cockayne syndrome cells.

Sugita K, Suzuki N, Higuchi Y, Kita K, Suzuki Y, Lehmann A.

Mutat Res. 1998 Jul;408(1):67-72.

PMID:
9678065
19.

The founding members of xeroderma pigmentosum group G produce XPG protein with severely impaired endonuclease activity.

Lalle P, Nouspikel T, Constantinou A, Thorel F, Clarkson SG.

J Invest Dermatol. 2002 Feb;118(2):344-51.

20.

The XPG story.

Clarkson SG.

Biochimie. 2003 Nov;85(11):1113-21.

PMID:
14726017

Supplemental Content

Support Center